Davide Bosso Selected Research

XRP6258

1/2016

Lack of Cumulative Toxicity Associated With Cabazitaxel Use in Prostate Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Davide Bosso Research Topics

Disease

9	Prostatic Neoplasms (Prostate Cancer) 04/2018 - 01/2013
8	Neoplasms (Cancer) 01/2022 - 12/2011
3	Melanoma (Melanoma, Malignant) 01/2022 - 03/2021
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2019 - 09/2012
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2018 - 11/2016
2	Febrile Neutropenia 01/2016 - 01/2013
2	Neutropenia 01/2016 - 01/2013
2	Neoplasm Metastasis (Metastasis) 03/2013 - 02/2013
1	Second Primary Neoplasms (Neoplasms, Second) 07/2021
1	Hepatocellular Carcinoma (Hepatoma) 10/2020
1	Fibrosis (Cirrhosis) 10/2020
1	Hepatitis 10/2020
1	COVID-19 10/2020
1	Fatigue 01/2018
1	Kidney Neoplasms (Kidney Cancer) 01/2018
1	Anemia 01/2016
1	Brain Neoplasms (Brain Tumor) 06/2014
1	Acquired Immunodeficiency Syndrome (AIDS) 05/2013
1	Lymphatic Metastasis 03/2013
1	Unknown Primary Neoplasms 03/2013
1	Carcinoma (Carcinomatosis) 03/2013
1	Hypocalcemia 02/2013
1	Renal Insufficiency (Renal Failure) 02/2013

Drug/Important Bio-Agent (IBA)

7	Docetaxel (Taxotere)FDA Link 04/2018 - 03/2013
6	cabazitaxel FDA Link 01/2017 - 01/2013
3	Immune Checkpoint InhibitorsIBA 11/2021 - 10/2020
2	Cisplatin (Platino)FDA LinkGeneric 07/2021 - 03/2013
2	enzalutamideIBA 04/2018 - 06/2017
2	Prednisone (Sone)FDA LinkGeneric 01/2017 - 01/2016
1	Antineoplastic Agents (Antineoplastics)IBA 11/2021
1	PlatinumIBA 07/2021
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 03/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 03/2021
1	B7-H1 AntigenIBA 10/2020
1	ErbB Receptors (EGF Receptor)IBA 08/2019
1	Tyrosine Kinase InhibitorsIBA 08/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2018
1	Prostate-Specific Antigen (Semenogelase)IBA 04/2018
1	abirateroneIBA 04/2018
1	EnzymesIBA 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	Sunitinib (Sutent)FDA Link 01/2018
1	isoquercitrinIBA 01/2018
1	taxaneIBA 01/2017
1	Monoclonal AntibodiesIBA 11/2016
1	TOR Serine-Threonine KinasesIBA 11/2016
1	MTOR InhibitorsIBA 11/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2016
1	Hormones (Hormone)IBA 01/2016
1	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2016
1	XRP6258IBA 01/2016
1	Carboplatin (JM8)FDA LinkGeneric 06/2014
1	Etoposide (VP 16)FDA LinkGeneric 06/2014
1	Denosumab FDA Link 02/2013
1	Zoledronic Acid (Zometa)FDA Link 02/2013
1	Calcitriol (Calcijex)FDA LinkGeneric 02/2013
1	Vitamin D FDA LinkGeneric 02/2013
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2013
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2013
1	Filgrastim (Neupogen)FDA Link 01/2013

Therapy/Procedure

9	Castration 04/2018 - 01/2013
6	Therapeutics 01/2022 - 09/2012
4	Drug Therapy (Chemotherapy) 01/2022 - 03/2013
3	Immunotherapy 01/2022 - 10/2020
2	Radiotherapy 03/2013 - 12/2011
1	Induction Chemotherapy 03/2013
1	Intravenous Infusions 03/2013